Bohai

Bohai Pharmaceuticals Group, Inc.

Bohai Pharmaceuticals Group, Inc.

(OTC: BOPH)

Corporate website • Investor Presentation_2014.7.28

A manufacturer and marketer of traditional Chinese medicine (TCM) in the People’s Republic of China, Bohai offers seven varieties of approved herbal medicines comprising four prescription drugs and three over-the-counter products in six delivery systems. The company reported net income of USD 19.1 million on revenue of USD 151.8 million for the year ended June 30, 2013, and net income of USD 18 million on revenue of USD 129.3 million for the first nine months of fiscal 2014.